Urology Times January 2, 2024
This year, the FDA authorized a multitude of new treatments and devices for use in urology practice. Here are the highlights.
February
LithoVue Elite System for ureteroscopy
The FDA granted 510(k) clearance to the LithoVue Elite Single-Use Digital Flexible Ureteroscope System.1 The device is the first of its kind, with the ability to monitor intrarenal pressure (IRP) in real time during ureteroscopy procedures to manage kidney stones, according to Boston Scientific Corporation. The LithoVue system includes a built-in pressure sensor on the tip of the ureteroscope to help urologists make informed clinical decisions during ureteroscopies, where fluid irrigation intended to provide a clear visual field can lead to elevated IRP.
March
New Illuccix indication for metastatic prostate cancer
The FDA...
Today's Sponsors
Today's Sponsor